Concepedia

Elliot DeHaan

ED

7

Publications

1.4K

Citations

7

H-Index

2000

Active since

Affiliations

Harvard University(Current)

Massachusetts General Hospital

University of Calgary

Brigham and Women's Hospital

Pfizer (United States)

Elliot DeHaan is an author at Harvard University specializing in autoimmunity, medicine, and host resistance.

Top concepts

Publications per year

2000–2024

7

Publications

7

Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults

Edward E. Walsh, Gonzalo Pérez Marc, Agnieszka Zareba et al. · New England Journal of Medicine · 2023 · 574 citations

SDF-1α induces chemotaxis and enhances Sonic hedgehog-induced proliferation of cerebellar granule cells

Robyn S. Klein, Joshua B. Rubin, Hilary D. Gibson et al. · Development · 2001 · 294 citations

IP-10 Is Critical for Effector T Cell Trafficking and Host Survival in Toxoplasma gondii Infection

Imtiaz A. Khan, James A. MacLean, Frederick S. Lee et al. · Immunity · 2000 · 283 citations · Full text

, , +9

Signal Transducer and Activator of Transcription 6 Controls Chemokine Production and T Helper Cell Type 2 Cell Trafficking in Allergic Pulmonary Inflammation

Anuja Mathew, James A. MacLean, Elliot DeHaan et al. · The Journal of Experimental Medicine · 2001 · 180 citations · Full text

CC Chemokine Receptor-2 Is Not Essential for the Development of Antigen-Induced Pulmonary Eosinophilia and Airway Hyperresponsiveness

James A. MacLean, George T. De Sanctis, Kate G. Ackerman et al. · The Journal of Immunology · 2000 · 35 citations · Full text

Rows per page

1–5 of 7